First Trust NYSE Arca Biotechnology Index Fund
FBT
#797
ETF Rang
€2.53 Mrd.
Marktkapitalisierung
🇺🇸 US
Markt
232,92 €
Aktienkurs
-1.04%
Veränderung (1 Tag)
54.15%
Veränderung (1 Jahr)
Kategorien

First Trust NYSE Arca Biotechnology Index Fund - Bestände

ETF-Bestände zum Stand 4. September 2026Anzahl der Bestände: 31

Vollständige Bestandsliste

Gewichtung %NameTickerGehaltene Aktien
4.43%
Halozyme Therapeutics, Inc.HALO1188143
3.82%
Regeneron Pharmaceuticals, Inc.REGN136243
3.78%
NeoGenomics, Inc.NEO6416474
3.73%
Natera, Inc.NTRA335386
3.72%
Corcept Therapeutics Inc.CORT985377
3.69%
Amgen Inc.AMGN249143
3.68%
BeOne Medicines Ltd. (ADR)ONC303104
3.64%
Sarepta Therapeutics, Inc.SRPT4777645
3.61%
argenx SE (ADR)ARGX103163
3.56%
Gilead Sciences, Inc.GILD697344
3.56%
Repligen CorporationRGEN627681
3.55%
Genmab A/S (ADR)GMAB3121944
3.52%
Illumina, Inc.ILMN476004
3.48%
BioNTech SE (ADR)BNTX989580
3.45%
BioMarin Pharmaceutical Inc.BMRN1531399
3.45%
Vertex Pharmaceuticals IncorporatedVRTX186520
3.40%
Biogen Inc.BIIB454617
3.33%
Incyte CorporationINCY775742
3.25%
ADMA Biologics, Inc.ADMA9970973
3.20%
Exelixis, Inc.EXEL1602410
3.11%
Bio-Techne CorporationTECH1269793
3.09%
Madrigal Pharmaceuticals, Inc.MDGL168689
3.00%
TG Therapeutics, Inc.TGTX1585019
2.99%
Bruker CorporationBRKR1507431
2.73%
Alnylam Pharmaceuticals, Inc.ALNY303041
2.73%
United Therapeutics CorporationUTHR165498
2.72%
Alkermes PlcALKS1743095
2.71%
Axsome Therapeutics, Inc.AXSM387241
2.69%
Neurocrine Biosciences, Inc.NBIX511187
2.29%
Veracyte, Inc.VCYT1589193
0.11%
US Dollar$USD3252660